日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Influenza A virus Nucleoprotein (NP) CSB-YP715711IBM
CSB-EP715711IBM
CSB-BP715711IBM
CSB-MP715711IBM
CSB-EP715711IBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Influenza A virus Neuraminidase (NA), partial CSB-YP715712IBL
CSB-EP715712IBL
CSB-BP715712IBL
CSB-MP715712IBL
CSB-EP715712IBL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Influenza A virus Matrix protein 1 (M) CSB-YP715713IGJ
CSB-EP715713IGJ
CSB-BP715713IGJ
CSB-MP715713IGJ
CSB-EP715713IGJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Influenza A virus Hemagglutinin (HA), partial CSB-YP715714IBW
CSB-EP715714IBW
CSB-BP715714IBW
CSB-MP715714IBW
CSB-EP715714IBW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cricetulus griseus NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial (NDUFB11), partial CSB-YP715715DXU1
CSB-EP715715DXU1
CSB-BP715715DXU1
CSB-MP715715DXU1
CSB-EP715715DXU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Uncharacterized protein C21orf59 homolog CSB-YP715716DIL
CSB-EP715716DIL
CSB-BP715716DIL
CSB-MP715716DIL
CSB-EP715716DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio H/ACA ribonucleoprotein complex subunit 3 (nop10) CSB-YP715717DIL
CSB-EP715717DIL
CSB-BP715717DIL
CSB-MP715717DIL
CSB-EP715717DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Myb-binding protein 1A-like protein (mybbp1a), partial CSB-YP715718DIL
CSB-EP715718DIL
CSB-BP715718DIL
CSB-MP715718DIL
CSB-EP715718DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Serine/threonine-protein kinase MRCK gamma (CDC42BPG), partial CSB-YP715719HU
CSB-EP715719HU
CSB-BP715719HU
CSB-MP715719HU
CSB-EP715719HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Solanum lycopersicum Translationally-controlled tumor protein homolog (TCTP) CSB-YP715720SZY
CSB-EP715720SZY
CSB-BP715720SZY
CSB-MP715720SZY
CSB-EP715720SZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse LEM domain-containing protein 2 (Lemd2), partial CSB-YP715721MO1
CSB-EP715721MO1
CSB-BP715721MO1
CSB-MP715721MO1
CSB-EP715721MO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana UPF0496 protein At1g20180 (At1g20180), partial CSB-YP715722DOA1
CSB-EP715722DOA1
CSB-BP715722DOA1
CSB-MP715722DOA1
CSB-EP715722DOA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maize mosaic virus Glycoprotein G (G), partial CSB-YP715723MEAS1
CSB-EP715723MEAS1
CSB-BP715723MEAS1
CSB-MP715723MEAS1
CSB-EP715723MEAS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana UPF0496 protein At3g28310/At3g28320 (At3g28310/At3g28320), partial CSB-YP715724DOA1
CSB-EP715724DOA1
CSB-BP715724DOA1
CSB-MP715724DOA1
CSB-EP715724DOA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytoplasmic polyadenylation element-binding protein 3 (cpb-3), partial CSB-YP715725CGAA
CSB-EP715725CGAA
CSB-BP715725CGAA
CSB-MP715725CGAA
CSB-EP715725CGAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Telomeric DNA-binding factor trf1 (trf1) CSB-YP715726SXV
CSB-EP715726SXV
CSB-BP715726SXV
CSB-MP715726SXV
CSB-EP715726SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. indica Syn-copalyl diphosphate synthase (CPS4), partial CSB-YP715727OFF
CSB-EP715727OFF
CSB-BP715727OFF
CSB-MP715727OFF
CSB-EP715727OFF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rabbit Tachykinin-4 (TAC4) CSB-YP715728RB
CSB-EP715728RB
CSB-BP715728RB
CSB-MP715728RB
CSB-EP715728RB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human DNA-directed RNA polymerase II subunit GRINL1A, isoforms 4/5 (POLR2M) CSB-YP715729HU
CSB-EP715729HU
CSB-BP715729HU
CSB-MP715729HU
CSB-EP715729HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Orthogeomys underwoodi Cytochrome c oxidase subunit 1 (MT-CO1), partial CSB-YP715730OAAU
CSB-EP715730OAAU
CSB-BP715730OAAU
CSB-MP715730OAAU
CSB-EP715730OAAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×